Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:: mid-season analysis 2012/13

J. McMenamin; N. Andrews; Charles Robertson; D.M. Fleming; H. Durnall; B. von Wissmann; J Ellis; A. Lackenby; S. Cottrell; B. Smyth; Maria Zambon; C. Moore; J. M. Watson; R.G. Pebody

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13

J. McMenamin, N. Andrews, Charles Robertson, D.M. Fleming, H. Durnall, B. von Wissmann, J Ellis, A. Lackenby, S. Cottrell, B. Smyth, Maria Zambon, C. Moore, J. M. Watson, R.G. Pebody

Mathematics And Statistics

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Abstract

The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

Original language	English
Article number	1
Journal	Eurosurveillance
Volume	18
Issue number	5
Publication status	Published - 31 Jan 2013

Keywords

influenza B
flu vaccine
trivalent influenza vaccine
vaccine effectiveness

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

McMenamin, J., Andrews, N., Robertson, C., Fleming, D. M., Durnall, H., von Wissmann, B., Ellis, J., Lackenby, A., Cottrell, S., Smyth, B., Zambon, M., Moore, C., Watson, J. M., & Pebody, R. G. (2013). Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Eurosurveillance, 18(5), Article 1.

@article{916f1704b27a43d2aed19a7219b685a3,

title = "Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:: mid-season analysis 2012/13",

abstract = "The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza. ",

keywords = "influenza B, flu vaccine, trivalent influenza vaccine, vaccine effectiveness ",

author = "J. McMenamin and N. Andrews and Charles Robertson and D.M. Fleming and H. Durnall and {von Wissmann}, B. and J Ellis and A. Lackenby and S. Cottrell and B. Smyth and Maria Zambon and C. Moore and Watson, {J. M.} and R.G. Pebody",

year = "2013",

month = jan,

day = "31",

language = "English",

volume = "18",

journal = "Eurosurveillance",

issn = "1560-7917",

number = "5",

}

McMenamin, J, Andrews, N, Robertson, C, Fleming, DM, Durnall, H, von Wissmann, B, Ellis, J, Lackenby, A, Cottrell, S, Smyth, B, Zambon, M, Moore, C, Watson, JM & Pebody, RG 2013, 'Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13', Eurosurveillance, vol. 18, no. 5, 1.

TY - JOUR

T1 - Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:

T2 - mid-season analysis 2012/13

AU - McMenamin, J.

AU - Andrews, N.

AU - Robertson, Charles

AU - Fleming, D.M.

AU - Durnall, H.

AU - von Wissmann, B.

AU - Ellis, J

AU - Lackenby, A.

AU - Cottrell, S.

AU - Smyth, B.

AU - Zambon, Maria

AU - Moore, C.

AU - Watson, J. M.

AU - Pebody, R.G.

PY - 2013/1/31

Y1 - 2013/1/31

N2 - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

AB - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

KW - influenza B

KW - flu vaccine

KW - trivalent influenza vaccine

KW - vaccine effectiveness

UR - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20393

M3 - Article

SN - 1560-7917

VL - 18

JO - Eurosurveillance

JF - Eurosurveillance

IS - 5

M1 - 1

ER -

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this